Skip to main content
Oncotarget logoLink to Oncotarget
. 2019 Nov 12;10(61):6643. doi: 10.18632/oncotarget.27314

Correction: Metabolic pathway for the universal fluorescent recognition of tumor cells

Ana Fernandez-Carrascal 1,#, Manuel Garcia-Algar 1,#, Moritz Nazarenus 1, Alicia Torres-Nuñez 1, Luca Guerrini 1, Neus Feliu 2,3, Wolfgang J Parak 3, Eduardo Garcia-Rico 4,, Ramon A Alvarez-Puebla 1,5,
PMCID: PMC6859919  PMID: 31762944

This article has been corrected: Due to errors in figure preparation, panels A and B of Figure 4 were accidentally duplicated. The corrected Figure 4 is shown below. The authors declare that these corrections do not change the results or conclusions of this paper.

Original article: Oncotarget. 2017; 8:76108–76115. 76108-76115. https://doi.org/10.18632/oncotarget.18551

Figure 4.

Figure 4

(AE) Flow cytometry plots of MCF-7 and PBMCs samples with cell ratios (A) 1:10, (B) 1:100, (C) 1:1000, (D) 1:10000 and (E) only PBMCs; upon incubation with 2-NBDG and CD45-APC for 30 minutes under hyperoxia conditions. (FI) Distributions of fluorescence intensities for (F) 2-NBDG and (G) CD45-APC, in a sample with a 1:1000 MCF-7:PBMC ratio; and (H) 2-NBDG and (I) CD45-APC, in a sample of PBMC. Over 106 single-cell events were collected for each experiment.


Articles from Oncotarget are provided here courtesy of Impact Journals, LLC

RESOURCES